Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Manley

Showing results (311-320 of 378) with videos related to

Pageof 38
Sort By:
European Urology Focus|January 6, 2020
Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to ImmunotherapySaif Zaman, Ali Hajiran, George A Coba, et al.
JAMA Network Open|May 25, 2021
Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell CarcinomaNicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.
BJU International|October 26, 2022
Antegrade administration of mitomycin gel for upper tract urothelial carcinoma via percutaneous nephrostomy tube: a multi-institutional retrospective cohort studyKyle M Rose, Gopal Narang, Geoffrey Rosen, et al.
The Journal of Urology|May 25, 2021
Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder CancerNicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.
Research Square|May 2, 2025
Plasma Cell-Free DNA Methylation-Based Prognosis in Metastatic Castrate-Resistant Prostate CancerJodie Wong, Yijun Tian, Manishkumar S Patel, et al.
Trials|November 7, 2023
Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trialKate L Francis, Christopher J D McKinlay, C Omar F Kamlin, et al.
Clinical Genitourinary Cancer|July 22, 2019
Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution SeriesJozefina Casuscelli, Maria F Becerra, Kenneth Seier, et al.
British Journal of Cancer|October 7, 2020
Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5Eric D Young, Sharon J Manley, Thomas C Beadnell, et al.
Kidney Medicine|October 3, 2023
Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of SeroresponseCaroline M Hsu, Daniel E Weiner, Harold J Manley, et al.
European Urology Oncology|February 16, 2023
Cost Effectiveness of Treatment Sequences in Advanced Renal Cell CarcinomaNeil T Mason, Vidhu B Joshi, Jacob J Adashek, et al.
Pageof 38

Showing results (311-320 of 378) with videos related to

Sort By:
Pageof 38
European Urology Focus|January 6, 2020
Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to ImmunotherapySaif Zaman, Ali Hajiran, George A Coba, et al.
JAMA Network Open|May 25, 2021
Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell CarcinomaNicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.
BJU International|October 26, 2022
Antegrade administration of mitomycin gel for upper tract urothelial carcinoma via percutaneous nephrostomy tube: a multi-institutional retrospective cohort studyKyle M Rose, Gopal Narang, Geoffrey Rosen, et al.
The Journal of Urology|May 25, 2021
Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder CancerNicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.
Research Square|May 2, 2025
Plasma Cell-Free DNA Methylation-Based Prognosis in Metastatic Castrate-Resistant Prostate CancerJodie Wong, Yijun Tian, Manishkumar S Patel, et al.
Trials|November 7, 2023
Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trialKate L Francis, Christopher J D McKinlay, C Omar F Kamlin, et al.
Clinical Genitourinary Cancer|July 22, 2019
Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution SeriesJozefina Casuscelli, Maria F Becerra, Kenneth Seier, et al.
British Journal of Cancer|October 7, 2020
Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5Eric D Young, Sharon J Manley, Thomas C Beadnell, et al.
Kidney Medicine|October 3, 2023
Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of SeroresponseCaroline M Hsu, Daniel E Weiner, Harold J Manley, et al.
European Urology Oncology|February 16, 2023
Cost Effectiveness of Treatment Sequences in Advanced Renal Cell CarcinomaNeil T Mason, Vidhu B Joshi, Jacob J Adashek, et al.
Pageof 38